Epstein Becker Green’s Bradley Merrill Thompson and Kim Tyrrell-Knott Represent Becton Dickinson in $12 Billion Acquisition – Media Coverage Roundup

Multiple Publications

Epstein Becker Green’s representation as health regulatory counsel to its client Becton, Dickinson and Company, a medical technology company, in conducting health regulatory due diligence and negotiating the terms of a purchase agreement to be used in connection with the client’s acquisition of CareFusion Corporation, an international medical products manufacturer, was mentioned by The Am Law Daily and Law360.

Epstein Becker Green attorneys Bradley Merrill Thompson and Kim Tyrrell-Knott led a team that conducted the preliminary due diligence on various health regulatory issues, particularly U.S. Food and Drug Administration and privacy and security matters.

The Am Law Daily, “Am Law Firms Land Roles on BD's $12 Billion Health Care Deal,” 10/6/2014

Law360, 10/5/2014